| TDP-43: a key therapeutic target beyond amyotrophic lateral sclerosis V Palomo, C Tosat-Bitrian, V Nozal, S Nagaraj, A Martin-Requero, ... ACS chemical neuroscience 10 (3), 1183-1196, 2019 | 56 | 2019 |
| From Kinase Inhibitors to Multitarget Ligands as Powerful Drug Leads for Alzheimer's Disease using Protein‐Templated Synthesis V Nozal, A García‐Rubia, EP Cuevas, C Pérez, C Tosat‐Bitrián, ... Angewandte Chemie 133 (35), 19493-19503, 2021 | 23 | 2021 |
| Increasing brain permeability of PHA-767491, a cell division cycle 7 kinase inhibitor, with biodegradable polymeric nanoparticles E Rojas-Prats, C Tosat-Bitrián, L Martínez-González, V Nozal, DI Pérez, ... Pharmaceutics 13 (2), 180, 2021 | 17 | 2021 |
| CdSe quantum dots evaluation in primary cellular models or tissues derived from patients C Tosat-Bitrián, V Palomo Nanomedicine: Nanotechnology, Biology and Medicine 30, 102299, 2020 | 13 | 2020 |
| Effect of clinically used microtubule targeting drugs on viral infection and transport function MÁ Oliva, C Tosat-Bitrián, L Barrado-Gil, F Bonato, I Galindo, ... International journal of molecular sciences 23 (7), 3448, 2022 | 8 | 2022 |
| CdSe Quantum Dots in Human Models Derived From ALS Patients: Characterization, Nuclear Penetration Studies and Multiplexing C Tosat-Bitrián, A Avis-Bodas, G Porras, D Borrego-Hernández, ... Nanomaterials 11 (3), 671, 2021 | 3 | 2021 |
| TTBK1 and CK1 inhibitors restore TDP-43 pathology and avoid disease propagation in lymphoblast from Alzheimer’s disease patients L Martinez-Gonzalez, EP Cuevas, C Tosat-Bitrián, V Nozal, C Gil, ... Frontiers in Molecular Neuroscience 16, 2023 | 2 | 2023 |
| Nanomedical research and development in Spain: improving the treatment of diseases from the nanoscale P Fernández-Gómez, C Pérez de la Lastra Aranda, C Tosat-Bitrián, ... Frontiers in Bioengineering and Biotechnology 11, 1191327, 2023 | 1 | 2023 |
| Estudio del potencial de bioconjugados Quantum Dots para el marcaje específico de dianas involucradas en Esclerosis Lateral Amiotrófica N Baños Sánchez, C Tosat Bitrián, V Palomo InnovARTE, Grupo Docente. Universidad de Alcalá, 2019 | 1 | 2019 |
| Biosensores específicos basados en quantum dots en la detección de proteínas patológicas en ELA CT Bitrián, A Martínez, V Palomo Dianas 7 (2), 1-10, 2018 | 1 | 2018 |
| Casein kinase 1 inhibitor avoids TDP-43 pathology propagation in a patient-derived cellular model of amyotrophic lateral sclerosis EP Cuevas, L Martinez-Gonzalez, C Gordillo, C Tosat-Bitrián, ... Neurobiology of Disease, 106430, 2024 | | 2024 |
| Nanomedical research and development in Spain: improving the treatment of diseases from the nanoscale P Fernández, C Pérez de la Lastra, C Tosat-Bitrian, JA Bueso de Barrio, ... Frontiers Media, 2023 | | 2023 |
| Biosensores para determinar la eficacia farmacológica en enfermedades neurodegenerativas C TOSAT BITRIÁN Biosensores para determinar la eficacia farmacológica en enfermedades …, 2023 | | 2023 |
| Biosensors to evaluate drug efficacy in neurodegenerative diseases C Tosat-Bitrian Universidad Complutense de Madrid, 2022 | | 2022 |
| Quantum dot conjugates in cellular models derived from patients: Towards molecular characterization and personalized medicine C Tosat-Bitrian, P Fernandez, A Martinez, A Martin-Requero, V Palomo JOURNAL OF NEUROCHEMISTRY 162, 127-128, 2022 | | 2022 |
| Use of peptide-fluorophore conjugates to asses putative targeting to glia of peptide-drug hybrid molecules as a new therapeutic approach for Multiple Sclerosis. F Josa-Prado, C Tosat-Bitrian, I Prieto-Mauricio, O Gutierrez-Jimenez, ... GLIA 69, E390-E391, 2021 | | 2021 |
| From kinase inhibitors to multitarget ligands as powerful drug leads for Alzheimer’s disease using protein-templated synthesis A Martínez, V Nozal, A García-Rubia, EP Cuevas, C Pérez, V Palomo, ... John Wiley & Sons, 2021 | | 2021 |
| P34 Measuring protein aggregation in lymphoblasts from als patients with a turbidometric assay C Pérez de la Lastra, C Tosat-Bitrian, V Nozal, A Martínez Gil, ... Sociedad Española de Química Terapéutica, 2021 | | 2021 |
| P47 Biosensors and cellular models derived from patients: towards molecular characterization and personalized medicine C Tosat-Bitrian, P Fernández, A Martínez Gil, Á Martín-Requero, ... Sociedad Española de Química Terapéutica, 2021 | | 2021 |
| CdSe Quantum Dots in human models derived from ALS patients: characterization and multiplexing studies C Tosat-Bitrian Real Sociedad Española de Química, 2021 | | 2021 |
